HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vuong Nguyen Selected Research

Blindness (Hysterical Blindness)

12/2022Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry.
11/2022Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
5/2022Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion.
5/2022Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry.
4/2022Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.
2/2022Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration.
2/2022Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.
1/2022Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.
1/2022Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project.
1/2022Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vuong Nguyen Research Topics

Disease

47Blindness (Hysterical Blindness)
12/2022 - 12/2016
34Macular Degeneration (Age-Related Maculopathy)
12/2022 - 08/2016
7Macular Edema
11/2022 - 01/2018
5Cataract (Cataracts)
04/2022 - 01/2018
4Retinal Vein Occlusion
11/2022 - 01/2022
3Choroidal Neovascularization
02/2022 - 01/2019
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 08/2016
3Fibrosis (Cirrhosis)
11/2021 - 01/2017
3Atrophy
11/2021 - 01/2020
2Retinal Detachment (Retinal Detachments)
11/2022 - 10/2018
2Retinal Diseases
11/2022 - 01/2020
2COVID-19
01/2022 - 10/2021
2Keratoconus
12/2021 - 01/2019
2Neoplasms (Cancer)
04/2019 - 07/2005
2Endophthalmitis (Ophthalmia)
01/2018 - 08/2016
1Ocular Hypertension (Glaucoma, Suspect)
01/2022
1Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2022
1Vision Disorders (Hemeralopia)
01/2022
1Low Tension Glaucoma
01/2022
1Usher Syndromes (Usher Syndrome)
12/2020
1Keratitis
08/2020
1Glaucoma
01/2020
1Uveal melanoma
04/2019
1Cicatrix (Scar)
01/2019
1Polypoidal Choroidal Vasculopathy
01/2019
1Inflammation (Inflammations)
01/2018
1Rupture
01/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2017
1Emphysema
01/2016
1Brain Neoplasms (Brain Tumor)
07/2005
1Neoplasm Metastasis (Metastasis)
07/2005
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2005
1Lymphoma (Lymphomas)
02/2005
1Hodgkin Disease (Hodgkin's Disease)
02/2005
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2005
1Infections
04/2004

Drug/Important Bio-Agent (IBA)

49Retinaldehyde (Retinal)IBA
12/2022 - 12/2016
27Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022 - 12/2016
16afliberceptIBA
12/2022 - 12/2016
15Ranibizumab (Lucentis)FDA Link
12/2022 - 08/2016
8Bevacizumab (Avastin)FDA Link
12/2022 - 01/2018
3Endothelial Growth FactorsIBA
07/2021 - 01/2019
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2022 - 01/2018
2Biomarkers (Surrogate Marker)IBA
12/2020 - 01/2017
2SteroidsIBA
08/2020 - 01/2018
1Antiglaucoma AgentsIBA
04/2022
1SmokeIBA
09/2020
1Eosine Yellowish-(YS) (Eosin)IBA
04/2019
1Sirtuin 2IBA
04/2019
1Formaldehyde (Formol)FDA Link
04/2019
1EnzymesIBA
04/2019
1Histone Deacetylase InhibitorsIBA
04/2019
1Histone Deacetylases (Histone Deacetylase)IBA
04/2019
1ParaffinIBA
04/2019
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2019
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2019
1N-acetyltryptophanamide (NATA)IBA
08/2016
1E-SelectinIBA
07/2005
1cysteine-rich fibroblast growth factor receptorIBA
07/2005
1P-selectin ligand proteinIBA
07/2005
1LigandsIBA
07/2005
1Proteins (Proteins, Gene)FDA Link
02/2005
1TNF Receptor-Associated Factor 1IBA
02/2005
1DNA (Deoxyribonucleic Acid)IBA
04/2004
1RNA (Ribonucleic Acid)IBA
04/2004

Therapy/Procedure

17Therapeutics
01/2022 - 01/2016
8Injections
01/2022 - 01/2018
7Intravitreal Injections
12/2022 - 08/2016
2Retreatment
10/2021 - 01/2018
1Phacoemulsification
01/2022
1Corneal Cross-Linking
12/2021
1Contact Lenses
08/2020
1Corneal Transplantation (Keratoplasty)
01/2019
1Photochemotherapy (Photodynamic Therapy)
01/2019
1Aftercare (After-Treatment)
10/2018
1Lasers (Laser)
01/2018
1Duration of Therapy
01/2018
1Intravenous Infusions
01/2016